4.7. Thrombin Generation Assay

RH Reza Haschemi
LG Lukas Maria Gockel
GB Gerd Bendas
MS Martin Schlesinger
request Request a Protocol
ask Ask a question
Favorite

Tumor cell-induced thrombin generation was evaluated using a fluorogenic thrombin generation assay. To eliminate the effects of the intrinsic coagulation system, platelet-rich-plasma was supplemented with Corn Trypsin Inhibitor (Santa Cruz Biotechnology). Tumor cells were added to a final concentration of 1 × 104 cells/mL. After adding the fluorogenic substrate Technothrombin TGA SUB (Technoclone GmbH, Vienna, Austria) and recalcification, the kinetic of the subsequent thrombin mediated Z-Gly-Gly-Arg-AMC cleavage was measured immediately and fluorescence was converted into thrombin concentrations using the evaluation software provided by Technoclone GmbH.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A